Excellos
A unique full-service CDMO, setting new standards in Cell & Gene Therapy
38 employees · est. 2021 · San Diego, United States
Shenji Bio
Advancing life sciences with essential raw materials, meeting clinical needs, and offering comprehensive solutions through innovative technology platforms.
est. 2018
Shenji Bio is the older company (2021 vs 2018).
Side-by-Side Comparison
| Metric | Excellos | Shenji Bio |
|---|---|---|
| Founded | ||
| Founded | 2021 | 2018 older |
| Headquarters | ||
| Headquarters | San Diego, United States | Not tracked yet |
| Employees | ||
| Employees | 38 | Not tracked yet |
| Industry | ||
| Industry | Biotechnology, Health Care, Life Sciences | Biotechnology |
| Funding Stage | ||
| Funding Stage | Corporate Round | Series A |
| Total Funding | ||
| Total Funding | $20.00M | $300.00M |
| Funding Rounds | ||
| Funding Rounds | 3 | 1 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Cell And Gene Therapy, CDMO, CGMP Manufacturing, TIL Therapies, CAR-T Therapy, Immunotherapy, Clinical Manufacturing, Life Science Research, Human Cell And Tissue Collection, Process Development, Global Scale Operations, Donor Pool Access, San Diego Blood Bank, Institutional Expertise | Life Sciences, Raw Materials, Research And Development, Nucleosides, Nucleotides, Diagnostic Antigens, Antibodies, IVD, MRNA, CGT, Technology Platforms, Clinical Needs, Innovation |
| Website | ||
| Website | excellos.com | syngenebio.com |
About Excellos
Excellos is a biotechnology startup based in the United States, founded in 2021. It operates as a unique full-service CDMO, focusing on cell and gene therapy innovation. Leveraging the expertise and resources of the San Diego Blood Bank with over 70 years of experience, Excellos aims to set a new in...
About Shenji Bio
Shenji Bio is a biotechnology startup founded in 2018, dedicated to advancing life sciences through the development of essential raw materials. Their focus on nucleosides, nucleotides, diagnostic antigens, and antibodies serves to address unmet clinical needs. The company has secured a CNY300.00M Se...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Excellos and Shenji Bio — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Excellos and Shenji Bio — by email.
Frequently Asked Questions
Compare Excellos with someone else
Start typing a company name or domain.